- Home
- HOOK vs IVP Comparison
HOOK vs IVP Comparison
Compare HOOK & IVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOOK
- IVP
- Stock Information
- Founded
- HOOK 2011
- IVP 2020
- Country
- HOOK United States
- IVP United States
- Employees
- HOOK N/A
- IVP N/A
- Industry
- HOOK Biotechnology: Pharmaceutical Preparations
- IVP Diversified Commercial Services
- Sector
- HOOK Health Care
- IVP Miscellaneous
- Exchange
- HOOK Nasdaq
- IVP Nasdaq
- Market Cap
- HOOK 9.3M
- IVP 7.8M
- IPO Year
- HOOK 2019
- IVP 2023
- Fundamental
- Price
- HOOK $1.59
- IVP $1.82
- Analyst Decision
- HOOK Buy
- IVP
- Analyst Count
- HOOK 4
- IVP 0
- Target Price
- HOOK $10.67
- IVP N/A
- AVG Volume (30 Days)
- HOOK 207.3K
- IVP 75.0K
- Earning Date
- HOOK 05-15-2025
- IVP 05-15-2025
- Dividend Yield
- HOOK N/A
- IVP N/A
- EPS Growth
- HOOK N/A
- IVP N/A
- EPS
- HOOK N/A
- IVP N/A
- Revenue
- HOOK $9,351,000.00
- IVP $15,399,751.00
- Revenue This Year
- HOOK N/A
- IVP N/A
- Revenue Next Year
- HOOK N/A
- IVP N/A
- P/E Ratio
- HOOK N/A
- IVP N/A
- Revenue Growth
- HOOK N/A
- IVP N/A
- 52 Week Low
- HOOK $0.72
- IVP $1.26
- 52 Week High
- HOOK $9.09
- IVP $401.50
- Technical
- Relative Strength Index (RSI)
- HOOK 59.36
- IVP 61.84
- Support Level
- HOOK $1.45
- IVP $1.43
- Resistance Level
- HOOK $1.62
- IVP $1.77
- Average True Range (ATR)
- HOOK 0.16
- IVP 0.21
- MACD
- HOOK -0.00
- IVP 0.01
- Stochastic Oscillator
- HOOK 67.57
- IVP 63.85
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.
About IVP Inspire Veterinary Partners Inc.
Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.